New Drugs for Treating Gonorrhea and Rising Resistance

In this episode of the Rural Doc Alan podcast, host Neil Haley speaks with Dr. Alan Lindemann about a growing global health concern—drug-resistant gonorrhea. As cases of gonorrhea continue to rise in the U.S. and globally, Dr. Lindemann explains how bacteria are evolving, why certain treatments are no longer effective, and what new drugs are emerging to fight back. From understanding cephalosporins (the last-standing class of effective antibiotics) to exploring cutting-edge medications like Zoliflodacin (pronounced something like "JPO-cin"), this episode delivers critical insight into the shifting landscape of STI treatment and public health. 👨‍⚕️ Guest Expert: Dr. Alan Lindemann (Rural Doc Alan) Veteran OB-GYN and maternal health expert Committed to educating the public on safe healthcare practices Author of Pregnancy Your Way Website: www.ruraldocalan.com 🩺 What You’ll Learn in This Episode: 🧬 What is drug resistance? When bacteria evolve to survive antibiotic treatment, making traditional medications ineffective. 💊 Which drugs still work? Cephalosporins, especially ceftriaxone (Rocephin) at 500mg IM or IV, remain the go-to treatment in the U.S. 🔬 Tracking resistance: Suspected resistant strains are sent to the CDC for monitoring and research. 🚫 Outdated treatments: